Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449910) titled 'Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial' on Feb. 27.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: The First Affiliated Hospital of University of Science and Technology of China
Condition:
Acute Ichemic Stroke
Anterior Cerebral Artery Stroke
Baricitinib
Intervention:
Drug: 2mg Baricitinib
Drug: 4mg ...